We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.


Probe has developed microeye to change the way doctors take blood samples. Microeye provides a continous sample from venus blood without removing whole blood. When coupled with Probe’s continumon it gives the clinician continous data showing trends and rate of change.

  • Expired
  • £233,630
    raised of £499,968 goal
  • Expired
    13 Jul 2018
  • 10
  • 9.01%
    equity available
  • £5,049,066
    pre-money valuation
  • 15/07/1998
    incorporated 22 years ago
  • Syndicate Room
  • Technology EIS
View on Syndicate Room nextfin.uk may earn a commission from partners

The content below is news from around the world relating to @probesci

The below content is from social media taken from external sites and is not representative of the views of nextfin.uk or Probe.

Twitter feed: @probesci

Please sign in or register to nextfin.uk to comment on this pitch.

Sign In Register

Other pitches in Technology

  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph